We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ERNA market cap is 14.39M. The company's latest EPS is USD -0.4221 and P/E is -0.66.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 51k | 17k | 47k | 47k | 2.06M |
| Operating Income | -5.51M | -5.77M | -5.79M | -4.93M | -2.26M |
| Net Income | -5.59M | -6.16M | -6.65M | -5.54M | -26.6M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 19.81M | 5.8M | 0 | 0 | 68k |
| Operating Income | -1.76M | -6.31M | -113.73M | -27.23M | -21.14M |
| Net Income | -2.06M | -4.43M | -122.32M | -24.6M | -21.68M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 52.25M | 49.13M | 49.66M | 46.49M | 7.72M |
| Total Liabilities | 48.69M | 46.9M | 53.07M | 55.01M | 53.11M |
| Total Equity | 3.56M | 2.23M | -3.41M | -8.53M | -45.39M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.13M | 3.75M | 32.43M | 22.28M | 49.13M |
| Total Liabilities | 9.03M | 2.89M | 25.93M | 10.17M | 46.9M |
| Total Equity | 5.09M | 851k | 6.5M | 12.11M | 2.23M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.75M | -20.41M | -3.75M | -6.01M | -12.29M |
| Investing | N/A | -19k | -97k | -346k | -365k |
| Financing | 8.85M | 16.56M | 1.39M | 1.36M | 5.25M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.74M | -3.89M | -23.49M | -20.98M | -20.41M |
| Investing | -1.07M | 960k | -22.74M | -47k | -19k |
| Financing | -1.1M | 291k | 61.59M | 19.58M | 16.56M |
| Market Cap | 14.39M |
| Price to Earnings Ratio | -0.66 |
| Price to Sales Ratio | 215.38 |
| Price to Cash Ratio | 1.9 |
| Price to Book Ratio | 6.44 |
| Dividend Yield | - |
| Shares Outstanding | 51.37M |
| Average Volume (1 week) | 620.38k |
| Average Volume (1 Month) | 2.17M |
| 52 Week Change | -85.02% |
| 52 Week High | 2.625 |
| 52 Week Low | 0.2212 |
| Spread (Intraday) | 0.02 (6.3%) |
| Company Name | Eterna Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://eternatx.com |
| Industry | television broadcast station (4833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
